<code id='462A2E9FA6'></code><style id='462A2E9FA6'></style>
    • <acronym id='462A2E9FA6'></acronym>
      <center id='462A2E9FA6'><center id='462A2E9FA6'><tfoot id='462A2E9FA6'></tfoot></center><abbr id='462A2E9FA6'><dir id='462A2E9FA6'><tfoot id='462A2E9FA6'></tfoot><noframes id='462A2E9FA6'>

    • <optgroup id='462A2E9FA6'><strike id='462A2E9FA6'><sup id='462A2E9FA6'></sup></strike><code id='462A2E9FA6'></code></optgroup>
        1. <b id='462A2E9FA6'><label id='462A2E9FA6'><select id='462A2E9FA6'><dt id='462A2E9FA6'><span id='462A2E9FA6'></span></dt></select></label></b><u id='462A2E9FA6'></u>
          <i id='462A2E9FA6'><strike id='462A2E9FA6'><tt id='462A2E9FA6'><pre id='462A2E9FA6'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:326
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          New study raises questions about niacin and heart health
          New study raises questions about niacin and heart health

          MattRourke/APNiacin,orvitaminB3,haslongbeenaU.S.publichealthdarlingtothepointthatitisadded,bylaw,toc

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Opioid cravings were reduced by anti

          Packetsofbuprenorphine,usedtotreatopioidusedisorder.Asmalltrialfoundreducedcravingswhenthisdrugwaspa